Management Change/Compensation Form 8 K

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Director Resignation

On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the "Board") notification of their resignations from the Board of FibroGen, Inc. (the "Company"), effective September 30, 2024. Ms. Blaug, Dr. Cravatt, and Mr. Lema's resignations as directors are not the result of any disagreement with the Company or its management on any matter relating to the Company's operations, policies, or practices.

Ms. Blaug joined the Company in June 2019 and served in a number of capacities during her tenure with the Company, including as Chair and a member of the Compensation Committee, and as a member of the Nominating and Corporate Governance Committee.

Dr. Cravatt joined the Company in August 2020 and served in a number of capacities during his tenure with the Company, including as a member of the Nominating and Corporate Governance Committee.

Mr. Lema joined the Company in September 2017 and served in a number of capacities during his tenure with the Company, including as a member of the Audit Committee and Compensation Committee.

The Company is extremely grateful for their service over the years, and wish Ms. Blaug, Dr. Cravatt, and Mr. Lema the best in their future endeavors. We have benefitted greatly from their counsel and direction.

New Committee Assignments

As a result of the foregoing director resignations, the Board appointed new chairmanships and memberships for each Board committee, effective as of September 30, 2024: the Audit Committee will be comprised of Mr. Jeffrey L. Edwards as Chair, Dr. Maykin Ho, and Mr. James A. Schoeneck; the Compensation Committee will be comprised of Mr. James A. Schoeneck as Chair, and Dr. Aoife Brennan; and the Nominating and Corporate Governance Committee will be comprised of Mr. James A. Schoeneck as Chair, and Mr. Jeffrey L. Edwards.